Skip to main content
. 2018 Aug 30;10(6):686–697. doi: 10.4168/aair.2018.10.6.686

Fig. 2. Patient flow.

Fig. 2

R, randomization; BIS, budesonide inhalation suspension; MONT, eligible and receiving montelukast; OBS, not eligible and receiving montelukast; EDN, eosinophil-derived neurotoxin; HDM, house dust mite.